Director/PDMR Shareholding

Spire Healthcare Group PLC

14 March 2025

 

Spire Healthcare Group plc

14 March 2025

Notification of Transactions of Persons Discharging Managerial Responsibilities

Grant of Deferred Share Bonus Plan (DSBP) Awards

Spire Healthcare Group plc (the Company) announces that on 13 March 2025, awards (the DSBP Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Company's DSBP.

Under the DSBP, Executive Directors are required to defer a proportion of their gross bonus, received in respect of the financial year ended 31 December 2024, into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DSBP:

Director	Percentage deferral of 2024 gross bonus*	Deferred Shares
Justin Ash	33%	65,896
Harbant Samra	33%	24,730

* To be disclosed in the 2024 Annual Report and Accounts

The share price used to determine the number of Deferred Shares subject to award was 176.0 pence, being the mid-market closing share price on 12 March 2025 (the dealing day prior to the awards being made).

The DSBP Awards will vest on the third anniversary of the grant date on 13 March 2028.

The transaction place is London.

Name of contact for queries:

Amie Gramlick                                                            [e-mail]

Director of Investor Relations

Spire Healthcare Group plc

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Justin Ash
2	Reason for the notification
a)	Position/status	Chief Executive Officer/PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	213800IBJPW3SE2RA350
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BNLPYF73
b)	Nature of the transaction	Grant of performance share awards under the Company's Deferred Share Bonus Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	65,896
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2025-03-13
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Harbant Samra
2	Reason for the notification
a)	Position/status	Chief Financial Officer/PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	213800IBJPW3SE2RA350
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BNLPYF73
b)	Nature of the transaction	Grant of performance share awards under the Company's Deferred Share Bonus Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	24,730
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2025-03-13
f)	Place of the transaction	XLON

 

END